Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2004-12-08
2008-01-22
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C514S563000
Reexamination Certificate
active
07321056
ABSTRACT:
The present invention is directed to a novel compound, its composition and use of a compound having a structural formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases
REFERENCES:
patent: 6294580 (2001-09-01), Willson et al.
patent: 2005/0171204 (2005-08-01), Lindstedt et al.
patent: WO 03/051821 (2003-06-01), None
Crespo Rafael Ferritto
Martin-Ortega Finger Maria Dolores
Eli Lilly and Company
Eyler Yvonne
Katakam Sudhakar
Vorndran-Jones MaCharri
LandOfFree
Selective peroxisome proliferator activated receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective peroxisome proliferator activated receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective peroxisome proliferator activated receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3964020